Reviewer	Employment	Research grant	Other research support	Speakers’ bureau/honoraria	Expert witness	Ownership interest	Consultant/advisory board	Other
Charlotte Lee	Massachusetts General Hospital, Harvard Medical School	None	None	None	None	None	None	None
Christopher J. O’Donnell	VA Boston Healthcare System	None	None	None	None	None	None	None
Rupal O’Quinn	University of Pennsylvania	None	None	None	None	None	None	None
Heinrich Taegtmeyer	University of Texas Health Science Center at Houston	None	None	None	None	None	None	None
Sean M. Wu	Stanford University School of Medicine	Sanofi (research project on immune checkpoint inhibitor myocarditis)†	None	None	None	None	None	None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

^†Significant.